Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2026)

Axsome Therapeutics has reported Amortization - Intangibles for 5 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Amortization - Intangibles changed 0.0% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $6.4 million, changed 0.27% from the prior year.
• Amortization - Intangibles slipped to $1.6 million in Q1 2026 per AXSM's latest filing, from $1.6 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $1.6 million in Q3 2022 and troughed at $926000.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2023 and 2025: Amortization - Intangibles jumped 71.6% in 2023, then retreated 1.07% in 2025.
• Over 5 years, Amortization - Intangibles stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025, then decreased by 2.18% to $1.6 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.